Statement Of Cash Flows [Abstract]

PureTech Health plc - Filing #5879297

Concept 2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for finance income (cost)
4,773,000 USD
5,078,000 USD
138,924,000 USD
Adjustments for decrease (increase) in trade and other receivables
629,000 USD
9,750,000 USD
7,734,000 USD
Adjustments for decrease (increase) in other current assets
1,262,000 USD
2,834,000 USD
862,000 USD
Adjustments for gains (losses) on change in fair value of derivatives
USD
USD
8,163,000 USD
Adjustments for gain (loss) on disposals, property, plant and equipment
14,000 USD
318,000 USD
138,000 USD
Adjustments for gain (loss) on disposal of investments in subsidiaries, joint ventures and associates
151,808,000 USD
61,787,000 USD
27,251,000 USD
Cash flows from (used in) investing activities [abstract]
Purchase of interests in associates
14,400,000 USD
USD
19,961,000 USD
Purchase of financial instruments, classified as investing activities
308,942,000 USD
178,860,000 USD
248,733,000 USD
Proceeds from sales or maturity of financial instruments, classified as investing activities
357,447,000 USD
244,556,000 USD
50,000,000 USD
Cash flows from (used in) financing activities [abstract]
Proceeds from exercise of options
895,000 USD
1,153,000 USD
332,000 USD
Proceeds from issue of preference shares
68,100,000 USD
USD
USD
Proceeds from issue of bonds, notes and debentures
USD
USD
393,000 USD

Talk to a Data Expert

Have a question? We'll get back to you promptly.